Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1994;75:1050-1063

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Quaini, F.
Right arrow Articles by Anversa, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Quaini, F.
Right arrow Articles by Anversa, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure

Circulation Research, Vol 75, 1050-1063, Copyright © 1994 by American Heart Association


ARTICLES

End-stage cardiac failure in humans is coupled with the induction of proliferating cell nuclear antigen and nuclear mitotic division in ventricular myocytes

F Quaini, E Cigola, C Lagrasta, G Saccani, E Quaini, C Rossi, G Olivetti and P Anversa
Department of Pathology, University of Parma, Italy.

Proliferating cell nuclear antigen (PCNA) is a late growth-regulated gene that is expressed at the G1-S boundary of the cell cycle and is required for DNA synthesis and cell proliferation. Since quantitative results suggest that myocyte hyperplasia occurs in the decompensated human heart, we postulated that induction of the PCNA gene may be present in the failing heart in humans. PCNA protein was detected in myocardial samples obtained from the left and right ventricles of patients with congestive heart failure. Endomyocardial biopsies collected from donor subjects were used as control tissue. The percentage of positively stained myocyte nuclei in the ventricles was established by using PCNA monoclonal antibody and the immunoperoxidase technique. The localization of PCNA in myocytes was confirmed by alpha- sarcomeric actin antibody staining. PCNA labeling was present in left ventricular myocytes of 29 of the 32 hearts examined. In the right ventricle, 24 of the 29 samples showed positive staining. In a subset of 25 patients, the percentage of PCNA-labeled myocyte nuclei was measured and found to constitute 49 +/- 22% of left ventricular myocytes. A similar analysis for the right ventricle, conducted in 21 patients, showed that 49 +/- 19% of the myocyte nuclei exhibited PCNA protein. In addition, mitotic figures in myocytes were documented. A quantitative analysis of this cellular process revealed that 11 myocyte nuclei per 1 million cells exhibited mitotic images in chronic heart failure. Immediately after myocardial infarction, two cells per million showed mitotic division, and this phenomenon was restricted to the region adjacent to the necrotic tissue. No PCNA labeling or nuclear mitotic images were detected in the ventricular myocardium of control subjects. Thus, the observation that diffuse PCNA labeling and myocyte mitotic division are present in hearts with end-stage failure strongly suggests that adult ventricular myocytes are not terminally differentiated cells and that myocyte cellular hyperplasia may constitute a growth reserve mechanism of the diseased heart.


This article has been cited by other articles:


Home page
Circ. Res.Home page
Cardiovascular Regenerative Medicine: The Developing Heart Meets Adult Heart Repair
Circ. Res., November 20, 2009; 105(11): 1041 - 1043.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. C. Kolwicz, S. M. MacDonnell, B. F. Renna, P. O. Reger, R. Seqqat, K. Rafiq, Z. V. Kendrick, S. R. Houser, A. Sabri, and J. R. Libonati
Left ventricular remodeling with exercise in hypertension
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1361 - H1368.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. Nadal-Ginard, J. Kajstura, A. Leri, and P. Anversa
Myocyte Death, Growth, and Regeneration in Cardiac Hypertrophy and Failure
Circ. Res., February 7, 2003; 92(2): 139 - 150.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
O. O. Al-Radi, V. Rao, R.-k. Li, T. Yau, and R. D. Weisel
Cardiac cell transplantation: closer to bedside
Ann. Thorac. Surg., February 1, 2003; 75(2): S674 - 677.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
F. B. Engel, L. Hauck, M. Boehm, E. G. Nabel, R. Dietz, and R. von Harsdorf
p21CIP1 Controls Proliferating Cell Nuclear Antigen Level in Adult Cardiomyocytes
Mol. Cell. Biol., January 15, 2003; 23(2): 555 - 565.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Anversa, B. Nadal-Ginard, D. A. Taylor, P. J. Goldschmidt, R. Hruban, and E. R. Rodriguez
Cardiac Chimerism: Methods Matter * Response
Circulation, October 29, 2002; 106 (18): e129 - e131.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
P. A. Poole-Wilson
Death or repair of the myocyte in chronic heart failure
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1104 - 1105.
[Full Text] [PDF]


Home page
HypertensionHome page
F. Z. Ammarguellat, P. O. Gannon, F. Amiri, and E. L. Schiffrin
Fibrosis, Matrix Metalloproteinases, and Inflammation in the Heart of DOCA-Salt Hypertensive Rats: Role of ETA Receptors
Hypertension, February 1, 2002; 39(2): 679 - 684.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. P. Beltrami, K. Urbanek, J. Kajstura, S.-M. Yan, N. Finato, R. Bussani, B. Nadal-Ginard, F. Silvestri, A. Leri, C. A. Beltrami, et al.
Evidence That Human Cardiac Myocytes Divide after Myocardial Infarction
N. Engl. J. Med., June 7, 2001; 344(23): 1750 - 1757.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mustapha, A. Kirshner, D. De Moissac, and L. A. Kirshenbaum
A direct requirement of nuclear factor-kappa B for suppression of apoptosis in ventricular myocytes
Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H939 - H945.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Kajstura, B. Pertoldi, A. Leri, C.-A. Beltrami, A. Deptala, Z. Darzynkiewicz, and P. Anversa
Telomere Shortening Is an in Vivo Marker of Myocyte Replication and Aging
Am. J. Pathol., March 1, 2000; 156(3): 813 - 819.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
G. Olivetti, E. Cigola, R. Maestri, C. Lagrasta, D. Corradi, and F. Quaini
Recent advances in cardiac hypertrophy
Cardiovasc Res, January 1, 2000; 45(1): 68 - 75.
[Full Text] [PDF]


Home page
CirculationHome page
M. Kanoh, G. Takemura, J. Misao, Y. Hayakawa, T. Aoyama, K. Nishigaki, T. Noda, T. Fujiwara, K. Fukuda, S. Minatoguchi, et al.
Significance of Myocytes With Positive DNA In Situ Nick End-Labeling (TUNEL) in Hearts With Dilated Cardiomyopathy : Not Apoptosis but DNA Repair
Circulation, June 1, 1999; 99(21): 2757 - 2764.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
P.B.J. Burton, M.H. Yacoub, and P.J.R. Barton
Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development
Eur. Heart J., April 2, 1999; 20(8): 604 - 611.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Kajstura, A. Leri, N. Finato, C. Di Loreto, C. A. Beltrami, and P. Anversa
Myocyte proliferation in end-stage cardiac failure in humans
PNAS, July 21, 1998; 95(15): 8801 - 8805.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. Anversa and J. Kajstura
Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart
Circ. Res., July 13, 1998; 83(1): 1 - 14.
[Full Text] [PDF]


Home page
Circ. Res.Home page
P. L. Kozlovskis, M. J.D. Smets, W. L. Strauss, and R. J. Myerburg
DNA Synthesis in Adult Feline Ventricular Myocytes : Comparison of Hypoxic and Normoxic States
Circ. Res., February 1, 1996; 78(2): 289 - 301.
[Abstract] [Full Text]